{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:42:34Z","timestamp":1774017754604,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.autrev.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T00:31:03Z","timestamp":1469925063000},"page":"978-982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)"],"prefix":"10.1016","volume":"15","author":[{"given":"Maria","family":"Weiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.016_bb0010","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2 Suppl. 41","key":"10.1016\/j.autrev.2016.07.016_bb0015","first-page":"S82","article-title":"Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants","volume":"24","author":"Mahr","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneph.2013.225","article-title":"Treatment of ANCA-associated vasculitis","volume":"10","author":"Schonermarck","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.016_bb0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.016_bb0030","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.016_bb0040","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.016_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.016_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2014.01.023","article-title":"The diagnosis and classification of microscopic polyangiitis","volume":"48-49","author":"Kallenberg","year":"2014","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2215\/CJN.03550807","article-title":"Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known","volume":"3","author":"de Lind van Wijngaarden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2016.07.016_bb0060","first-page":"i150","article-title":"Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?","volume":"30","author":"de Joode","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.016_bb0065","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League against Rheumatism Systemic Vasculitis Task Force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.016_bb0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0b013e32834d2d52","article-title":"Animal models of antineutrophil cytoplasm antibody-associated vasculitis","volume":"24","author":"Salama","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.016_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.018","article-title":"Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg\u2013Strauss syndrome)","volume":"48-49","author":"Mouthon","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2016.07.016_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2014.01.024","article-title":"Diagnosis and classification of Goodpasture's disease (anti-GBM)","volume":"48-49","author":"Hellmark","year":"2014","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.016_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00124743-199710000-00002","article-title":"Clinical and laboratory features and disease outcome of Kawasaki disease: the analysis of our experience and literature review","volume":"3","author":"Generini","year":"1997","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2249.1994.tb06013.x","article-title":"Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch\u2013Schonlein purpura","volume":"95","author":"Ronda","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.016_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","article-title":"A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease","volume":"86","author":"Saxon","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"10.1016\/j.autrev.2016.07.016_bb0105","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.016_bb0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ard.59.11.898","article-title":"Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis","volume":"59","author":"Locht","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.016_bb0115","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: a prospective follow-up study","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.016_bb0120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2016.07.016_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40064-015-0835-8","article-title":"Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome","volume":"4","author":"Draibe","year":"2015","journal-title":"Springerplus"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.016_bb0130","first-page":"1127","article-title":"Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis","volume":"26","author":"Wiik","year":"1974","journal-title":"Immunology"},{"issue":"22","key":"10.1016\/j.autrev.2016.07.016_bb0135","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.016_bb0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.1780380509","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance","volume":"38","author":"Schnabel","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.016_bb0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01325.x","article-title":"False-positive myeloperoxidase binding activity due to DNA\/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies","volume":"121","author":"Jethwa","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.016_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.016_bb0155","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.38389","article-title":"Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis","volume":"66","author":"Mahr","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.016_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcf.2006.10.005","article-title":"Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis","volume":"6","author":"Carlsson","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.016_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/rheumatology\/keg066","article-title":"Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis","volume":"42","author":"Flores-Suarez","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.016_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02560504","article-title":"Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection","volume":"27","author":"Cornely","year":"1999","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.016_bb0175","first-page":"270","article-title":"ANCA seropositivity in HIV: a serological pitfall","volume":"63","author":"Jansen","year":"2005","journal-title":"Neth J Med"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.1994.tb06578.x","article-title":"Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody","volume":"97","author":"Pudifin","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.016_bb0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.autrev.2013.01.005","article-title":"Prognosis of vasculitis associated myelodysplasia","volume":"12","author":"Belizna","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12185-009-0341-2","article-title":"Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin's and non-Hodgkin lymphoma: a single center experience","volume":"90","author":"Cil","year":"2009","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.016_bb0195","first-page":"153","article-title":"Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies","volume":"32","author":"Esnault","year":"1990","journal-title":"J Clin Lab Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.016_bb0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01910215","article-title":"Drug-induced glomerular disease: immune-mediated injury","volume":"10","author":"Hogan","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.016_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","article-title":"Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Gao","year":"2009","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.016_bb0210","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.2010.198","article-title":"Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals","volume":"78","author":"Cui","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2016.07.016_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev217","article-title":"Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission","author":"Soderberg","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:02:43Z","timestamp":1568246563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1568997216301616"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.016","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}